Sedative-hypnotics and osteoporotic fractures: A systematic review of observational studies with over six million individuals

Abstract

<p>We reviewed and meta-analyzed 20 observational studies to examine the relationship between sedative-hypnotic use and osteoporotic fractures. We searched PubMed, Embase, APA PsycINFO, and Web of Science™ for studies that used cohort, case-control, case-crossover, and self-controlled case series designs. We further assessed the quality of each study and performed meta-analyses of association estimates, e.g., odds ratios (ORs). The analysis included 6,084,083 participants and found a slight association between the use of sedative-hypnotics and osteoporotic fractures, with differing strength of associations between different classes of drugs and greater sedative-hypnotics exposure. The pooled estimates ORs for case-control studies were 1.33 (95% CI 0.98–1.80) with benzodiazepines (BZD) and any fractures, 1.32 (95% CI 1.05–1.66) with BZDs and hip fractures, and case-crossover studies were 1.15 (95% CI 0.95–1.41) with BZDs and any fractures, 1.41 (95% CI 1.08–1.85) with Z-drugs and any fractures. The study suggests that more research is needed to aid medical professionals in balancing this potential risk of osteoporotic fractures associated with sedative-hypnotic use against other reported adverse events and anticipated therapy outcomes.</p>